Yahoo May Look to A...
Health Care: Drugs
Horizon Pharma Inc (HZNP: NASDAQ)
$2.40 -0.01 | -0.41%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -87.79M | -113.26M | -27.06M | -20.50M |
| Operating Gains/Losses | 76.00K | 3.00M | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -1.09M | -1.82M | -516.00K | 0.00 |
| (Increase) Decrease in Inventories | -4.02M | -923.00K | 1.01M | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -2.21M | 5.64M | -1.14M | 137.00K |
| (Decrease) Increase In Other Current Liabilities | 7.05M | 3.22M | -2.40M | 1.09M |
| (Increase) Decrease In Other Working Capital | -3.17M | -12.58M | 4.53M | 0.00 |
| Other Non-Cash Items | 9.52M | 72.15M | -16.44M | -79.00K |
| Net Cash From Continuing Operations | -76.64M | -41.54M | -37.53M | -18.39M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -76.64M | -41.54M | -37.53M | -18.39M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 260.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.34M | -1.60M | -714.00K | -617.00K |
| Acquisitions | 0.00 | 0.00 | 6.49M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -50.00K | -550.00K | -200.00K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.39M | -2.15M | 5.58M | -357.00K |
| Issuance of Debt | 55.58M | 23.42M | 0.00 | 9.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 128.52M | 44.80M | 20.68M | 7.02M |
| Repayment of Long-Term Debt | -19.79M | -13.07M | -10.98M | -4.18M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 20.06M | 1.00K |
| Net Cash From Financing Activities | 164.31M | 55.15M | 29.76M | 11.84M |
| Effect of Exchange Rate Changes | -160.00K | 1.12M | 421.00K | 0.00 |
| Net Change in Cash & Cash Equivalents | 86.12M | 12.58M | -1.78M | -6.91M |
Portfolios with HZNP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Facing FDA Ap...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest HZNP Headlines from TheStreet
- 3 Stocks Under $10 Making Big Moves 03.15.13 | 07:03 am
- January Effect Stock Picks Here Are 7 Possible Winners For 2013 12.28.12 | 03:12 pm
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 5 Stocks Insiders Love Right Now 10.03.12 | 01:10 pm
- Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 02:08 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
- Horizon Pharma: Rayos FDA Approval Thursday Seems Likely 07.25.12 | 10:07 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
Press Releases for HZNP
- Horizon Pharma Announces Completion Of Sales Force Expansion - PR Newswire 10.01.12 | 07:10 am
- Horizon Pharma Announces Receipt Of Two Additional U.S. Patent Allowances For DUEXIS® - PR Newswire 09.28.12 | 07:09 am
- Horizon Pharma Announces FDA Approval Of RAYOS® (prednisone) Delayed-Release Tablets For Rheumatoid Arthritis And Multiple Additional Indications - PR Newswire 07.26.12 | 04:07 pm
- The Grünenthal Group Enters Into Exclusive Agreement With Horizon Pharma For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 08:06 am
- Horizon Pharma Enters Into Exclusive Agreement With Grunenthal For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 07:06 am
- Horizon Pharma And Mallinckrodt, The Pharmaceuticals Business Of Covidien, Enter Into Co-Promotion Agreement For DUEXIS® In The United States - PR Newswire 06.18.12 | 06:06 am
- Horizon Pharma Announces Issuance Of U.S. Patent Covering RAYOS (delayed-release Prednisone) - PR Newswire 05.29.12 | 07:05 am
Partner Headlines for HZNP
- Horizon Pharma Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 05.09.13 | 08:05 am
- Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO - NASDAQ 03.15.13 | 08:03 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet - Benzinga 10.15.12 | 09:10 am
- Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play - Seeking Alpha 10.07.12 | 08:10 am
- Morning Market Losers - Benzinga 09.20.12 | 01:09 pm
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- 6 Healthcare Stocks With Pending August Catalysts - Seeking Alpha 08.01.12 | 09:08 am
- 4 Hot Healthcare Stocks Making Mid-Week Noise - Seeking Alpha 07.25.12 | 09:07 am
